miR-200b inhibits CD133+ glioma cells by targeting the AKT pathway

@inproceedings{Liu2017miR200bIC,
  title={miR-200b inhibits CD133+ glioma cells by targeting the AKT pathway},
  author={Aiqun Liu and Qingyun Yu and Zhongxing Peng and Yeqing Huang and Shengpeng Diao and Jing Cheng and Wentao Wang and Ming-fan Hong},
  booktitle={Oncology letters},
  year={2017}
}
MicroRNA-200b (miR-200b) is a tumor suppressor in multiple tumor types, including gastric cancer, breast cancer, ovarian cancer and glioma. The biological significance of a known normal and cancer stem cell marker, CD133, remains elusive. The aim of the present study was to identify the function and mechinism of miR-200b in suppressing CD133+ glioma cells. CD133+ glioma cells were sorted by flow cytometry. The expression of miR-200b, Ki67, GAP43, GFAP and CD133 were tested by reverse… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Targeting of miR34 aNOTCH 1 axis reduced breast cancer stemness and chemoresistance

EY Park, E Chang, +7 authors H Suzuki
Cancer Res • 2014

Similar Papers

Loading similar papers…